Testing an Omega-3 Fatty Acid-Based Anti-Cancer Therapy for Patients With Triple-Negative Inflammatory Breast Cancer That Has Spread to Other Parts of the Body
Clinical trial NCT05198843 · TERMINATED
Trial details
- NCT number
- NCT05198843
- Sponsor
- National Cancer Institute (NCI)
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-08
- Primary completion
- 2023-12-19
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.